June 26, 2007 (Press Release) --
This report discusses US ethical pharmaceuticals for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, distribution and commercial status, product segmentation, regulatory considerations, market environment, distribution and commercial status forecasts, product forecasts, industry composition and leading participants. Product segments cover cardiovascular agents, central nervous system agents, anti-infective agents, gastrointestinal agents, respiratory agents, and other agents. Pharmaceutical demand by distribution status (ethical and over-the-counter) and commercial status (proprietary and generic) is also included. This 17 page report also includes a highlights summary and resources section.
Companies Profiled
GlaxoSmithKline
Johnson & Johnson
Pfizer Incorporated
Table of Contents
HIGHLIGHTS
INDUSTRY OVERVIEW
Market Size
Distribution & Commercial Status
Product Segmentation
Regulatory Considerations
INDUSTRY TRENDS & FORECASTS
Market Environment
Distribution & Commercial Status Forecasts
Product Forecasts
INDUSTRY STRUCTURE
Industry Composition
Industry Leaders
RESOURCES
Focus Report Overview
Each Freedonia Focus provides access to a wealth of industry insights and analysis
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8689
Companies Profiled
GlaxoSmithKline
Johnson & Johnson
Pfizer Incorporated
Table of Contents
HIGHLIGHTS
INDUSTRY OVERVIEW
Market Size
Distribution & Commercial Status
Product Segmentation
Regulatory Considerations
INDUSTRY TRENDS & FORECASTS
Market Environment
Distribution & Commercial Status Forecasts
Product Forecasts
INDUSTRY STRUCTURE
Industry Composition
Industry Leaders
RESOURCES
Focus Report Overview
Each Freedonia Focus provides access to a wealth of industry insights and analysis
For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8689

This report discusses US ethical pharmaceuticals for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, distribution and commercial status, product segmentation
Email
Print
SPAM
LEAVE A COMMENT





